Characteristic | Reference intervals | TT (n = 195) | CT + CC (n = 119) | P |
---|---|---|---|---|
Alanine amiotransferase (U/L)a | 0-46 | 38.0 (28.0, 66.0) | 39.5 (28.3, 90.3) | 0.470 |
Aspartate aminotransferase, (U/L)a | 0-46 | 44.0 (30.0, 68.0) | 47.0 (32.3, 90.3) | 0.385 |
Total bilirubin (μmol/L)a | 0-25 | 18.7 (13.3, 25.4) | 19.1 (14.3, 27.9) | 0.615 |
Direct bilirubin (μmol/L)a | 0-7 | 4.7 (3.4, 6.6) | 5.5 (4.1, 8.5) | 0.031 |
Indirect bilirubin (μmol/L)a | 1.5-18 | 13.9 (9.7,1 8.6) | 14.2 (10.0, 19.1) | 0.965 |
Total protein (g/L)a | 60-80 | 68.0 (61.5, 73.2) | 68.6 (63.6, 74.1) | 0.307 |
Albumin (g/L)b | 35-55 | 40.4 ± 6.2 | 39.8 ± 5.5 | 0.378 |
Globulin (g/L)a | 20-30 | 27.1 (23.5, 30.3) | 29.1 (24.9, 32.1) | 0.034 |
Albumin/Globulina | 1.5-2.5 | 1.5 (1.3, 1.7) | 1.4 (1.3, 1.7) | 0.099 |
γ-glutamyltransferase (U/L)a | 5-55 | 55.0 (40.0, 99.0) | 73.0 (37.0, 191.0) | 0.022 |
Alkaline phosphatase (U/L)a | 35-134 | 92.0 (74.0, 120.0) | 108.5 (84.5, 136.8) | 0.002 |
5-Nucleotidase (U/L)a | 0-10 | 3.0 (2.0, 5.0) | 3.0 (2.0, 7.5) | 0.236 |
Total biliary acid (μmol/L)a | 0-15 | 6.9 (3.5, 13.9) | 9.3 (4.5, 19.4) | 0.149 |
Cholinesterase (U/L)a | 3000-10500 | 6264.2 ± 2351.8 | 5645.5 ± 2225.7 | 0.028 |
Pre-albumin (mg/L)a | 100-400 | 125.5 (69.7, 168.9) | 100.0 (70.0, 176.3) | 0.374 |
Glucose (mmol/L)a | 3.9-6.2 | 5.0 (4.5, 5.8) | 5.2 (4.7, 5.9) | 0.085 |
Blood urea nitrogen (mmol/L)a | 1.7-7.2 | 5.0 (3.5, 5.8) | 5.1 (3.9, 6.4) | 0.187 |
Creatinine (μmol/L)a | 45-117 | 73.8 (65.5, 84.0) | 73.8 (61.9, 83.7) | 0.187 |
Uric acid (μmol/L)b | 119-417 | 252.0 ± 87.4 | 256.9 ± 87.3 | 0.642 |
Retinol-binding protein (mg/L)a | 15-70 | 28.0 (17.9, 34.6) | 27.9 (15.9, 38.2) | 0.695 |
Cystatin C (mg/L)a | 0-1.2 | 1.1 (0.9, 1.2) | 1.0 (0.9, 1.3) | 0.782 |
Carcinoembryonic antigen,(ng/mL)a | 0-5 | 2.1 (1.4, 3.4) | 2.3 (1.6, 1.9) | 0.365 |
Alpha-fetoprotein (ng/mL)a | 0-20 | 181.7 (10.9, 1000.0) | 99.2 (8.4, 691.2) | 0.164 |
Ferritin (ng/mL)a | 0-322 | 196.8 (126.7, 361.2) | 277.9 (161.0, 424.6) | 0.212 |
Cancer antigen 125 (KU/L)a | 0-35 | 15.2 (10.1, 31.7) | 16.0 (8.6, 45.5) | 0.707 |
Cancer antigen 153 (KU/L)a | 0-35 | 10.4 (7.6, 14.1) | 9.6 (7.3, 14.3) | 0.720 |
Cancer antigen 199 (KU/L)a | 0-35 | 13.3 (7.1, 23.7) | 12.4 (6.6, 26.8) | 0.585 |
Prothrombin time (sec)a | 10.5-13.5 | 12.0 (11.3, 12.8) | 11.9 (10.9, 13.2) | 0.875 |
PT% (%)a | 80-130 | 91.3 (82.0, 104.0) | 93.5 (79.8, 109.0) | 0.744 |
International standard ratioa | 0.85-1.15 | 1.0 (1.0, 1.1) | 1.0 (1.0, 1.2) | 0.815 |
D-fibrinogen (g/L)a | 2-4 | 2.7 (2.2, 3.4) | 2.6 (2.3, 3.3) | 0.724 |
activated partial thrombo-plastin time (sec)b | 28-40 | 34.8 ± 7.3 | 34.3 ± 7.9 | 0.568 |
Thrombin time (sec)a | 11-14 | 14.4 (13.8, 15.5) | 14.5 (13.5, 15.5) | 0.886 |